Share / Print

James Brigaitis

James Brigaitis

Leonard N. Stern School of Business
Tisch Hall
40 West Fourth Street, 803
New York, NY 10012



Jim Brigaitis has more than 30 years of experience as a pharmaceutical and biologics marketing executive. During his career, Jim has held senior positions in diverse organizations ranging from the world’s largest pharmaceutical company to a start-up firm.

A key focus during Jim’s career has been launching complex innovations and transforming biopharmaceutical markets. He has led the strategic planning and marketing efforts for a number of multi-billion dollar products that have redefined the standard of care in a variety of disease categories. These include Aricept (alzhiemer’s disease), Diflucan (infectious diseases), Lyrica (pain and fibromyagia), Viagra (erectile dysfunction), and Zoloft (depression).

Jim is currently the President and Founder of a consulting firm that specializes in commercial strategy for new and emerging biopharmaceutical companies. Prior to that, Jim was Vice President of Worldwide Marketing and Commercial Development for Pfizer’s $7 billion neurosciences portfolio. He was also a member of a small executive team that secured venture capital funding to form a new company that successfully developed and out-licensed a novel antibiotic (Solosec).

Courses Taught

  • Innovation in Pharma and Biologics

Academic Background

M.B.A., Marketing and Finance
University of Chicago

B.A., Economics
Northwestern University